Biodesix, Inc. BDSX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $88.5M+24.1% | $71.32M+45.3% | $49.09M+28.5% | $38.21M-29.9% | ||
| $12M+25.5% | $9.56M-4.3% | $9.99M-23.8% | $13.1M+2.4% | ||
| $87.55M+8.8% | $80.45M+19.4% | $67.39M+9.6% | $61.46M+21.7% | ||
| $116.37M+10.0% | $105.82M+17.0% | $90.43M+1.8% | $88.8M-7.0% | ||
| $116.37M+10.0% | $105.82M+17.0% | $90.43M+1.8% | $88.8M-7.0% | ||
| -$27.87M+19.2% | -$34.5M+16.6% | -$41.34M+18.3% | -$50.59M-23.6% | ||
| -31.5%+16.9pp | -48.4%+35.9pp | -84.2%+48.2pp | -132.4%-57.3pp | ||
| $7.72M-6.6% | $8.26M-13.4% | $9.54M+18.1% | $8.07M+79.1% | ||
| -$7.39M+12.3% | -$8.43M+21.9% | -$10.8M+27.3% | -$14.86M-570% | ||
| -$35.27M+17.9% | -$42.93M+17.7% | -$52.15M+20.3% | -$65.45M-51.6% | ||
| -39.8%+20.3pp | -60.2%+46.0pp | -106.2%+65.0pp | -171.3%-92.1pp | ||
| -$3.19-20.4% | -$2.65-314% | -$0.64+59.2% | -$1.57+8.7% | ||
| -$3.19-20.4% | -$2.65-314% | -$0.64+59.2% | -$1.57— | ||
| 169M-29.0% | 238.1M-25.1% | 318.1M+108% | 152.9M+80.8% | ||
| 169M-29.0% | 238.1M-25.1% | 318.1M+108% | 152.9M— | ||
| $16.72M+7.4% | $15.57M+19.7% | $13.01M-8.1% | $14.15M-53.6% | ||
| $107K-55.0% | $238K— | —— | —— | ||
| —— | —— | -$10.8M+27.3% | -$14.86M-570% | ||
| -$27.87M+19.2% | -$34.5M+16.6% | -$41.34M+18.3% | -$50.59M-23.6% | ||
| -$22.2M+22.7% | -$28.72M+24.4% | -$38.01M+19.1% | -$46.99M-24.4% | ||
| -$22.2M+22.7% | -$28.72M+24.4% | -$38.01M+19.1% | -$46.99M-24.4% | ||
| -25.1%+15.2pp | -40.3%+37.2pp | -77.4%+45.5pp | -123%-53.7pp | ||
| -$27.87M+19.2% | -$34.5M+16.6% | -$41.34M+18.3% | -$50.59M-23.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Biodesix, Inc.'s revenue?
- Biodesix, Inc. (BDSX) generated $96.1M in revenue over the trailing twelve months, up 29.0% year over year.
- Is Biodesix, Inc. profitable?
- Biodesix, Inc. is not currently profitable: it reported a net loss of $32.0M over the trailing twelve months, a -33.3% net margin.
- What is Biodesix, Inc.'s earnings per share?
- Biodesix, Inc.'s diluted EPS over the trailing twelve months is $-2.48.
- Where does Biodesix, Inc.'s income statement data come from?
- Every line is extracted from Biodesix, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
